Employers Holdings, Inc. (NYSE:EIG) Q3 2023 Earnings Call Transcript

Employers Holdings, Inc. (NYSE:EIG) Q3 2023 Earnings Call Transcript October 26, 2023

Operator: Greetings, and welcome to Employers Holdings Inc. Third Quarter 2023 Earnings Conference Call. At this time all participants on a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder this conference is being recorded. It is now my pleasure to introduce Lori Brown, Chief Legal Officer. Thank you. You may begin.

Lori Brown: Thank you, Doug. Good morning and welcome everyone to the third quarter 2023 earnings call for Employers. Today’s call is being recorded and webcast from the Investors section of our website where a replay will be available following the call. Presenting today on the call will be Kathy Antonello, our Chief Executive Officer; and Mike Paquette, our Chief Financial Officer. Statements made during this conference call that are not based on historical facts are considered forward-looking statements. These statements are made in reliance on the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995. Although we believe the expectations expressed in our forward-looking statements are reasonable, risks and uncertainties could cause actual results to be materially different from our expectations, including the risks set forth in our filings with the Securities and Exchange Commission.

All remarks made during the call are current only at the time of the call and will not be updated to reflect subsequent developments. The company also uses its website as a means of disclosing material non-public information and for complying with disclosure obligations under SEC’s Regulation FD. Such disclosures will be included on the Investors section of the company’s website. Accordingly, investors should monitor that portion of the company’s website in addition to following the company’s press releases SEC filings, public conference calls and webcasts. In our earnings press release and in our remarks or responses to questions, we may use non-GAAP financial metrics. Reconciliations of these non-GAAP metrics to our GAAP results are included in our financial supplement as an attachment to our earnings press release, our investor presentation and any other materials available in the Investors section on our website.

Now, I’ll turn the call over to Kathy.

Kathy Antonello: Thank you, Lori. Good morning to everyone and thanks for joining us today. To start this morning, I’ll provide some highlights of our third quarter 2023 financial results then I’ll hand it over to Mike for more details on our financials. Prior to Q&A, I’ll share some additional commentary. Our third quarter results were solid. Our net written and earned premiums were up 4% and 3% respectively with wage increases a strong labor market our thoughtful appetite expansion program and our new sales and underwriting operating model, each contributing to this growth. As a result, we ended the quarter with more than 126,000 policies in force, a record level representing increases in each of the last 13 consecutive quarters.

Our net investment income was up 9%. The increase was due to higher market interest rates impacting bond yields, partially offset by lower invested balances of fixed income investments. Mike will speak more about our net investment income later in the call. From an underwriting standpoint, we maintained our current accident year loss and LAE ratio on voluntary business at 63.3%, below the 64% we maintained throughout 2022. As was the case a year ago, we did not recognize any prior year loss reserve development in the quarter because the full actuarial study was not performed and the amount of indicated net prior year loss reserve development was consistent with our expectations. We will evaluate our prior year reserves in more detail at year-end when we routinely perform a full reserve study.

Our total commissions and associated commission expense ratio were higher this quarter due to an increase in agency incentive accruals, which are specific to individual contracts and vary with agency growth and profitability. Our total underwriting and general and administrative expenses were also up slightly but the associated expense ratio remained consistent with that of a year ago when considering the increase in earnings premium. With that, I’ll turn the call over to Mike, and I’ll return to provide my closing remarks. Mike?

Mike Paquette: Thank you, Kathy. Gross premiums written were $196 million versus $189 million a year ago, an increase of 4%. The increase was primarily due to higher new and renewal business writings. Net premiums earned were $185 million versus $179 million a year ago, an increase of 3%. Our losses and loss adjustment expenses were $115 million versus $112 million a year ago. That increase was due to higher earned premiums partially offset by a lower current accident year loss in LAE provision. Commission expenses were $27 million versus $25 million a year ago. The increase was primarily due to higher earned premiums and higher 2023 agency incentive accruals. Underwriting and general and administrative expenses were $44 million versus $42 million a year ago.

The increase was primarily due to higher compensation-related expenses and higher policyholder dividends and bad debt expenses each of which resulted from the increase in earned premiums. From a reporting segment perspective, our Employers segment had pretax income of $21 million versus $26 million a year ago and its resulting calendar year combined ratios were each 98% for the period. From a reporting — I’m sorry, our Cerity segment had a pretax loss of $2 million in each period. Turning to investments. Our net investment income was $26 million versus $24 million a year ago. The increase was due to higher bond yields partially offset by lower invested asset balances as measured by amortized cost. The decrease in our invested assets year-over-year is largely the result of winding down our Federal Home Loan Bank leveraged investment strategy.

Pursuant to that strategy our insurance subsidiaries received advances from the FHLB throughout 2022 and the proceeds from these advances were used to purchase investment securities. Our fixed maturities currently have a duration of 4.4 and an average credit quality of A+. Our weighted average bond yield was 4.1% at quarter end and our new money rate today is in excess of 6%. Our net income this quarter was unfavorably impacted by $6 million of net after-tax unrealized losses from equity securities, and other investments which are reflected on our income statement and our stockholders’ equity was further impacted by $26 million of net after-tax unrealized losses from fixed maturity securities which are reflected on our balance sheet. During the third quarter of 2023, we repurchased 367,209 shares of our common stock at an average price of $38.95 per share and we currently have a remaining share repurchase authorization of $36 million.

Yesterday our Board of Directors declared a fourth quarter 2023 regular quarterly dividend of $0.28 per share. This dividend is payable on November 22 to shareholders of record on November 8. And now, I’ll turn the call back to Kathy.

Kathy Antonello : Thank you, Mike. We are currently laser-focused on integrating Cerity’s operations into those of Employers. After the consolidation effort is complete policies issued by Cerity and Employers will be administered and serviced consistently and redundant systems and processes will be eliminated generating additional efficiencies, and expense savings for the company. Through this initiative and others we remain confident that we can further reduce our total underwriting expenses in 2024, as a percentage of our earned premiums and I look forward to sharing our progress with you on that front at our next earnings call. Throughout the year, we’ve also been actively returning capital to our shareholders, which has enhanced our earnings per share and return on equity metrics.

Our capital management efforts this year, which have consisted of share repurchases and regular quarterly dividends totaled $22 million in the third quarter and $84 million year-to-date. These actions reflect our strong balance sheet abundant underwriting capital and confidence in the company’s future operations. In closing, as the unique specialist in small business workers’ compensation, we’ve never been better positioned to further benefit from the favorable trends and opportunities that we’re seeing and we remain highly confident in our continued success. And with that, operator we will now take questions.

See also 80 Dirty Funny Tinder Bios for Guys from Reddit and 25 Dumbest States in America.

Q&A Session

Operator: Thank you. Ladies and gentlemen, at this time, we will be conducting a question-and-answer session. [Operator Instructions] Our first question comes from the line of Mark Hughes with Truist. Please proceed with your question.

Mark Hughes: Yeah. Thanks. Good morning. Kathy, I think the new business or the premium growth excluding audit adjustments was up in the double digits again. You have talked about your expansion and appetite for new class codes. I wonder, if you could say, whether you think the environment on a go-forward basis is it good enough that it should allow you to kind of expand at a similar pace? Are you looking at other expansions that perhaps can increase your underwriting appetite? Just kind of a sense on the top line dynamic here.

Kathy Antonello: Yeah. Well let me give you a few numbers and then I’ll talk a little bit more about the appetite expansion effort. During the third quarter, we increased our audit accrual by $1.2 million and so that now stands at $40.2 million. That compares to what we did in Q3 of 2022 when we increased our audit accrual by $9 million. So, there’s a bit of a difference there. Also audit pickups remained strong in the third quarter that totaled about $7.4 million, which compares to $12.5 million in the third quarter of 2022. So when you exclude as you were mentioning all the final audit pick up and change in accrual amounts our gross written premium increased about 12% in the third quarter of 2023 relative to the third quarter of 2022.

So yes, we still do have double-digit growth when you take out the audit — the audit premium adjustments. We also recognized about $14.5 million in endorsements in the third quarter and that’s up $3.5 million from last year. In addition about $1.3 million came through in noncompliance premium. So as expired policies are being audited we endorse the in-force policies upward and to reflect that change in payroll and that’s generating a tailwind for endorsements. So we are bullish on our opportunities for growth. We continue to look at opportunities to expand our appetite and our — we formed a committee to do that. They are still in effect and we’re looking at class codes that we can open up in 2024 just to give you an idea of how that’s impacting our growth through September 30 new business was at $115 million of written premium and about $40 million of that is coming from our appetite expansion classes.

So we like what we’re seeing there. The loss ratio is coming in very similar to what we see — we’ve seen on our traditional target classes. And so we do expect to continue that effort.

Mark Hughes: Very good. And then health care inflation what’s your take? It seems like there’s some additional discussion but maybe not much sign of it yet. What do you think?

Kathy Antonello: Yeah. We’re certainly keeping an eye on it. Up to this point medical inflation in the economic data has been mild relative to the inflation that we’re seeing in other sectors like energy or housing and food. And so that’s good news. I can tell you that, internally this quarter we performed a study that looked just at prescription drugs and whether or not we’re seeing an inflationary impact on defined basket of pharmaceuticals. And we found that our internal drug cost index for in-network pharmacy costs had been — it’s been decreasing every year since 2019, but did experience an uptick in 2023. But despite that increase from 2022 to 2023 pharmacy costs are still lower now than they were back in 2019. So we have seen a little year-over-year increase after many years of decreasing, but it’s still lower than it was pre-pandemic.

Mark Hughes: Understood. Thank you very much.

Operator: [Operator Instructions] Our next question comes from the line of Bob Farnam with Janney. Please proceed with your question.

Bob Farnam: Hi, thanks and good morning. So thanks for the update on the expansion classes Kathy I just wanted to know what the average policy size is for that business? Is it bigger or smaller than your traditional book?